Evaluation of Safety of Acellular Dermal Matrix(ADM) in Breast Reconstruction

Recruiting now

Conditions studied: Breast Cancer Female, Breast Reconstruction

In brief

The goal of this observational study is to evaluate the safety of Acellular Dermal Matrix(ADM) processed by CO2 supercritical fluid technology against other acellular dermal matrix products from different companies that have been washed with detergents in patients undergoing breast reconstruction surgery with implants due to the breast cancer.

Key facts

Study ID
NCT06555614
Run by
DOF Inc.
People needed
120
Starts
2024-06-13
Expected to finish
2027-02-28
Last updated by the study team
2026-04-28

Who can join

Age: 19 and older, up to 79. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.